Literature DB >> 16895282

Depression and intelligence in patients with Parkinson's disease and deep-brain stimulation.

Courtney R Schadt1, Katie L Cox, Michael G Tramontana, Daniel W Byrne, Thomas L Davis, John Y Fang, Peter E Konrad, Bhavna Padaliya, Robert W Mutter, Chandler E Gill, Caralee R Richardson, P David Charles.   

Abstract

The goal of this study is to examine the association of depression with intelligence and education in patients with Parkinson's disease treated with bilateral subthalamic nucleus stimulation (STN-DBS). The literature has been contradictory concerning depression in Parkinson's disease patients. Some studies have shown less depression in Parkinson's disease patients with more education not treated with STN-DBS. Other recently published studies indicate that STN-DBS improves the depression associated with Parkinson's disease. No studies have examined the correlation of these factors with depression in Parkinson's disease patients treated with STN-DBS. We administered the Beck Depression Inventory (BDI) pre- and postoperatively to 21 Parkinson's disease patients (seven women, 14 men, ages 49-75) who underwent STN-DBS. The postoperative scores of the lower 50th percentile (n=8) of the Verbal Comprehensive Index of the Wechsler Adult Intelligence Scale (WAIS-III) decreased significantly (P=0.036), while the upper 50th percentile (n=13) remained nearly constant (P=0.802). Furthermore, as the education increased from highschool to graduate level, patients demonstrated less improvement in depressive symptoms postoperatively. These findings suggest that Parkinson's disease patients with lower intelligence test scores and less education benefit more with regards to depressive symptomatology after STN-DBS than patients with higher scores and education.

Entities:  

Mesh:

Year:  2006        PMID: 16895282      PMCID: PMC2569473     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  25 in total

1.  Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Authors:  Aurélie Funkiewiez; Claire Ardouin; Paul Krack; Valérie Fraix; Nadège Van Blercom; Jing Xie; Elena Moro; Alim-Louis Benabid; Pierre Pollak
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

2.  Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Jan Herzog; Jens Volkmann; Paul Krack; Florian Kopper; Monika Pötter; Delia Lorenz; Meike Steinbach; Stefan Klebe; Wolfgang Hamel; Bettina Schrader; Dieter Weinert; Dieter Müller; Hubertus M Mehdorn; Günther Deuschl
Journal:  Mov Disord       Date:  2003-11       Impact factor: 10.338

3.  Bilateral subthalamic nucleus stimulation improves health-related quality of life in PD.

Authors:  E Lagrange; P Krack; E Moro; C Ardouin; N Van Blercom; S Chabardes; A L Benabid; P Pollak
Journal:  Neurology       Date:  2002-12-24       Impact factor: 9.910

4.  The importance of educational and psychological factors in Parkinson's disease quality of life.

Authors:  E Cubo; A Rojo; S Ramos; S Quintana; M Gonzalez; K Kompoliti; M Aguilar
Journal:  Eur J Neurol       Date:  2002-11       Impact factor: 6.089

5.  Depression, socioeconomic status, age, and marital status in black women: a national study.

Authors:  Isabel C Scarinci; Bettina M Beech; Wendy Naumann; Kristen W Kovach; Letha Pugh; Bolaji Fapohunda
Journal:  Ethn Dis       Date:  2002       Impact factor: 1.847

Review 6.  Placement of deep brain stimulators into the subthalamic nucleus or Globus pallidus internus: technical approach.

Authors:  Philip A Starr
Journal:  Stereotact Funct Neurosurg       Date:  2002       Impact factor: 1.875

Review 7.  Prevalence, etiology, and treatment of depression in Parkinson's disease.

Authors:  William M McDonald; Irene H Richard; Mahlon R DeLong
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

8.  Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology.

Authors:  Alexander I Tröster; Julie A Fields; Steven Wilkinson; Rajesh Pahwa; William C Koller; Kelly E Lyons
Journal:  Stereotact Funct Neurosurg       Date:  2003       Impact factor: 1.875

9.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

10.  A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses.

Authors:  Stanley Zammit; Peter Allebeck; Anthony S David; Christina Dalman; Tomas Hemmingsson; Ingvar Lundberg; Glyn Lewis
Journal:  Arch Gen Psychiatry       Date:  2004-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.